BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34148870)

  • 1. Changes in the Long-term Prognosis of Crohn's Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study.
    Ye BD; Hong SN; Seo SI; Kim YJ; Cha JM; Rhee KH; Yoon H; Kim YH; Kim KH; Park SY; Jeong SK; Lee JH; Park H; Kim JS; Im JP; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Park SH; Yang SK;
    Gut Liver; 2022 Mar; 16(2):216-227. PubMed ID: 34148870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognosis of ulcerative colitis and its temporal changes between 1986 and 2015 in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea.
    Cha JM; Park SH; Rhee KH; Hong SN; Kim YH; Seo SI; Kim KH; Jeong SK; Lee JH; Park SY; Park H; Kim JS; Im JP; Yoon H; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Ye BD; Yang SK
    Gut; 2020 Aug; 69(8):1432-1440. PubMed ID: 31822581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Features and Long-term Prognosis of Crohn's Disease in Korea: Results from the Prospective CONNECT Study.
    Hong SW; Ye BD; Cheon JH; Lee JH; Koo JS; Jang BI; Lee KM; Kim YS; Kim TO; Im JP; Song GA; Jung SA; Kim HS; Park DI; Kim HS; Huh KC; Kim YH; Cha JM; Seo GS; Choi CH; Song HJ; Baik GH; Kim JW; Shin SJ; Park YS; Lee CK; Lee J; Jung SH; Jung Y; Park SC; Joo YE; Jeen YT; Han DS; Yang SK; Kim HJ; Kim WH; Kim JS
    Gut Liver; 2022 Nov; 16(6):907-920. PubMed ID: 35321956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors.
    Oh EH; Oh K; Han M; Seo H; Chang K; Lee SH; Kim GU; Song EM; Seo M; Lee HS; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
    PLoS One; 2017; 12(5):e0177479. PubMed ID: 28542298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Features and Long-Term Outcomes of Paediatric-Onset Inflammatory Bowel Disease in a Population-Based Cohort in the Songpa-Kangdong District of Seoul, Korea.
    Park SH; Im JP; Park H; Jeong SK; Lee JH; Rhee KH; Kim YH; Hong SN; Kim KH; Seo SI; Cha JM; Park SY; Kim JS; Yoon H; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Ye BD; Yang SK
    J Crohns Colitis; 2022 Feb; 16(2):207-215. PubMed ID: 34309652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.
    Targownik LE; Benchimol EI; Bernstein CN; Singh H; Lix L; Tennakoon A; Leung S; Aviña A; Coward S; Jones J; Kaplan G; Murthy SK; Nguyen GC; Peña-Sánchez JN
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1788-1798.e2. PubMed ID: 30448599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Ileocecal Resection for Crohn's Disease Is Associated With Improved Long-term Outcomes Compared With Anti-Tumor Necrosis Factor Therapy: A Population-Based Cohort Study.
    Agrawal M; Ebert AC; Poulsen G; Ungaro RC; Faye AS; Jess T; Colombel JF; Allin KH
    Gastroenterology; 2023 Oct; 165(4):976-985.e3. PubMed ID: 37321356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of thiopurine discontinuation at anti-tumour necrosis factor initiation in inflammatory bowel disease treatment: a nationwide Danish cohort study.
    Thomsen SB; Ungaro RC; Allin KH; Elmahdi R; Poulsen G; Andersson M; Colombel JF; Jess T
    Aliment Pharmacol Ther; 2022 May; 55(9):1128-1138. PubMed ID: 35080036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
    González-Lama Y; Suárez C; González-Partida I; Calvo M; Matallana V; de la Revilla J; Magaz M; Bernardo C; Agudo B; Ibarrola P; Relea L; Arévalo J; Vera MI; Abreu L
    J Crohns Colitis; 2016 Jan; 10(1):55-60. PubMed ID: 26520164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 30-year Trend Analysis in the Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District of Seoul, Korea in 1986-2015.
    Park SH; Kim YJ; Rhee KH; Kim YH; Hong SN; Kim KH; Seo SI; Cha JM; Park SY; Jeong SK; Lee JH; Park H; Kim JS; Im JP; Yoon H; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Ye BD; Yang SK;
    J Crohns Colitis; 2019 Oct; 13(11):1410-1417. PubMed ID: 30989166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
    Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term prognosis of crohn's disease and its temporal change between 1981 and 2012: a hospital-based cohort study from Korea.
    Park SH; Yang SK; Park SK; Kim JW; Yang DH; Jung KW; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Inflamm Bowel Dis; 2014 Mar; 20(3):488-94. PubMed ID: 24412992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014.
    Kirchgesner J; Lemaitre M; Rudnichi A; Racine A; Zureik M; Carbonnel F; Dray-Spira R
    Aliment Pharmacol Ther; 2017 Jan; 45(1):37-49. PubMed ID: 27781286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monotherapy with thiopurines in stricturing Crohn's disease: A real-life experience from low- and middle-income countries.
    Kante B; Vuyyuru SK; Kedia S; Sahu P; Kumar P; Ranjan MK; Virmani S; Sharma R; Madhusudhan KS; Panwar R; Das P; Makharia G; Ahuja V
    Indian J Gastroenterol; 2022 Aug; 41(4):343-351. PubMed ID: 35997952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Therapeutic Strategies Have Changed the Natural History of Pediatric Crohn's Disease: A Two-Decade Population-Based Study.
    Ley D; Leroyer A; Dupont C; Sarter H; Bertrand V; Spyckerelle C; Guillon N; Wils P; Savoye G; Turck D; Gower-Rousseau C; Fumery M;
    Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2588-2597.e1. PubMed ID: 35131345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor necrosis factor therapy decreases the risk of initial intestinal surgery after diagnosis of Crohn's disease of inflammatory type.
    Nagata Y; Esaki M; Moriyama T; Hirano A; Umeno J; Maehata Y; Torisu T; Matsumoto T; Kitazono T
    J Gastroenterol; 2019 Apr; 54(4):330-338. PubMed ID: 30244398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and long-term prognosis of Crohn's disease in Korea.
    Ye BD; Yang SK; Cho YK; Park SH; Yang DH; Yoon SM; Kim KJ; Byeon JS; Myung SJ; Yu CS; Kim JH
    Scand J Gastroenterol; 2010 Oct; 45(10):1178-85. PubMed ID: 20560811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics and Long-term Prognosis of Elderly-Onset Ulcerative Colitis in a Population-Based Cohort in the Songpa-Kangdong District of Seoul, Korea.
    Park SH; Jeong SK; Lee JH; Rhee KH; Kim YH; Hong SN; Kim KH; Seo SI; Cha JM; Park SY; Park H; Kim JS; Im JP; Yoon H; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Ye BD; Yang SK;
    Gut Liver; 2021 Sep; 15(5):742-751. PubMed ID: 33462161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of pneumonia among patients with inflammatory bowel disease.
    Long MD; Martin C; Sandler RS; Kappelman MD
    Am J Gastroenterol; 2013 Feb; 108(2):240-8. PubMed ID: 23295276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.